SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Pacira BioSciences, Inc. – ‘10-K’ for 12/31/23

On:  Thursday, 2/29/24, at 3:33pm ET   ·   For:  12/31/23   ·   Accession #:  1396814-24-30   ·   File #:  1-35060

Previous ‘10-K’:  ‘10-K’ on 2/28/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   33 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/29/24  Pacira BioSciences, Inc.          10-K       12/31/23  123:17M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        10-K - Pcrx - 12.31.2023                            HTML   2.73M 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     29K 
 7: EX-10.22    Material Contract                                   HTML     78K 
 8: EX-10.23    Material Contract                                   HTML    591K 
 9: EX-10.32    Material Contract                                   HTML     43K 
10: EX-10.33    Material Contract                                   HTML    121K 
11: EX-10.34    Material Contract                                   HTML    144K 
 3: EX-10.5     Material Contract                                   HTML     51K 
 4: EX-10.6     Material Contract                                   HTML     49K 
 5: EX-10.8     Material Contract                                   HTML     43K 
 6: EX-10.9     Material Contract                                   HTML     51K 
12: EX-21.1     Subsidiaries List                                   HTML     32K 
13: EX-23.1     Consent of Expert or Counsel                        HTML     32K 
17: EX-97       Clawback Policy re: Recovery of Erroneously         HTML     48K 
                Awarded Compensation                                             
14: EX-31.1     Certification -- §302 - SOA'02                      HTML     34K 
15: EX-31.2     Certification -- §302 - SOA'02                      HTML     34K 
16: EX-32.1     Certification -- §906 - SOA'02                      HTML     32K 
23: R1          Cover                                               HTML     98K 
24: R2          Audit Information                                   HTML     35K 
25: R3          Consolidated Balance Sheets                         HTML    145K 
26: R4          Consolidated Balance Sheets (Parenthetical)         HTML     51K 
27: R5          Consolidated Statements of Operations               HTML    121K 
28: R6          Consolidated Statements of Comprehensive Income     HTML     57K 
29: R7          Consolidated Statements of Stockholders' Equity     HTML    127K 
30: R8          Consolidated Statements of Cash Flows               HTML    165K 
31: R9          Description of Business                             HTML     36K 
32: R10         Summary of Significant Accounting Policies          HTML     78K 
33: R11         Recent Accounting Pronouncements                    HTML     44K 
34: R12         Revenue                                             HTML     87K 
35: R13         Flexion Acquisition                                 HTML     43K 
36: R14         Inventories                                         HTML     39K 
37: R15         Fixed Assets                                        HTML     45K 
38: R16         Leases                                              HTML     61K 
39: R17         Goodwill and Intangible Assets                      HTML     61K 
40: R18         Accrued Expenses                                    HTML     44K 
41: R19         Debt                                                HTML    101K 
42: R20         Financial Instruments                               HTML    155K 
43: R21         Stockholders' Equity                                HTML     58K 
44: R22         Stock Plans                                         HTML    144K 
45: R23         Net Income Per Share                                HTML     70K 
46: R24         Income Taxes                                        HTML    138K 
47: R25         Employee Benefit Plans                              HTML     38K 
48: R26         Contingent Consideration (Gains) Charges,           HTML     63K 
                Acquisition-Related Charges and Other                            
49: R27         Commercial Partners and Other Agreements            HTML     44K 
50: R28         Commitments and Contingencies                       HTML     52K 
51: R29         Subsequent Event                                    HTML     33K 
52: R30         Pay vs Performance Disclosure                       HTML     42K 
53: R31         Insider Trading Arrangements                        HTML     52K 
54: R32         Summary of Significant Accounting Policies          HTML    131K 
                (Policies)                                                       
55: R33         Summary of Significant Accounting Policies          HTML     60K 
                (Tables)                                                         
56: R34         Revenue (Tables)                                    HTML     78K 
57: R35         Flexion Acquisition (Tables)                        HTML     38K 
58: R36         Inventories (Tables)                                HTML     40K 
59: R37         Fixed Assets (Tables)                               HTML     46K 
60: R38         Leases (Tables)                                     HTML     61K 
61: R39         Goodwill and Intangible Assets (Tables)             HTML     56K 
62: R40         Accrued Expenses (Tables)                           HTML     44K 
63: R41         Debt (Tables)                                       HTML     78K 
64: R42         Financial Instruments (Tables)                      HTML    148K 
65: R43         Stockholders' Equity (Tables)                       HTML     53K 
66: R44         Stock Plans (Tables)                                HTML    145K 
67: R45         Net Income Per Share (Tables)                       HTML     70K 
68: R46         Income Taxes (Tables)                               HTML    135K 
69: R47         Contingent Consideration (Gains) Charges,           HTML     55K 
                Acquisition-Related Charges and Other - (Tables)                 
70: R48         Description of Business (Details)                   HTML     34K 
71: R49         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     48K 
                Schedule of Percentage of Revenue Comprised of the               
                Three Largest Wholesalers (Details)                              
72: R50         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     35K 
                Narrative (Details)                                              
73: R51         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fixed  HTML     41K 
                Assets (Details)                                                 
74: R52         REVENUE - Sales and Valuation Accruals (Details)    HTML     55K 
75: R53         REVENUE - Narrative (Details)                       HTML     37K 
76: R54         REVENUE - Schedule of Disaggregation of Net         HTML     48K 
                Product Sales (Details)                                          
77: R55         FLEXION ACQUISITION - Narrative (Details)           HTML     60K 
78: R56         FLEXION ACQUISITION - Schedule of Total             HTML     50K 
                Consideration (Details)                                          
79: R57         INVENTORIES - Components of Inventory (Details)     HTML     40K 
80: R58         FIXED ASSETS - Schedule of Major Categories         HTML     49K 
                (Details)                                                        
81: R59         FIXED ASSETS - Narrative (Details)                  HTML     46K 
82: R60         LEASES - Narrative (Details)                        HTML     39K 
83: R61         LEASES - Schedule of Operating Lease Cost and       HTML     49K 
                Other Operating Lease Information (Details)                      
84: R62         LEASES - Schedule of Maturities of Operating Lease  HTML     49K 
                Liabilities (Details)                                            
85: R63         GOODWILL AND INTANGIBLE ASSETS - Narrative          HTML     75K 
                (Details)                                                        
86: R64         GOODWILL AND INTANGIBLE ASSETS - Schedule of        HTML     55K 
                Intangible Assets (Details)                                      
87: R65         Accrued Expenses (Details)                          HTML     48K 
88: R66         DEBT - Carrying Value of Debt (Details)             HTML     54K 
89: R67         DEBT - Narrative (Details)                          HTML    244K 
90: R68         DEBT - Schedule of Debt (Details)                   HTML     63K 
91: R69         DEBT - Schedule of Interest Expense (Details)       HTML     46K 
92: R70         FINANCIAL INSTRUMENTS - Fair Value of Liabilities   HTML     85K 
                Measured on a Recurring Basis (Details)                          
93: R71         FINANCIAL INSTRUMENTS - Schedule of Investments     HTML     47K 
                Without Readily Determinable Fair Value (Details)                
94: R72         FINANCIAL INSTRUMENTS - Narrative (Details)         HTML     86K 
95: R73         FINANCIAL INSTRUMENTS - Schedule of Fair Value      HTML     42K 
                Inputs and Valuation (Details)                                   
96: R74         FINANCIAL INSTRUMENTS - Schedule of Changed in      HTML     37K 
                Contingent Consideration (Details)                               
97: R75         FINANCIAL INSTRUMENTS - Schedule of Investments at  HTML     89K 
                Amortized Cost and Fair Value (Details)                          
98: R76         STOCKHOLDERS' EQUITY - Narrative (Details)          HTML     46K 
99: R77         Stockholders' Equity - Aoci (Details)               HTML     54K 
100: R78         STOCK PLANS - Narrative (Details)                   HTML    103K  
101: R79         STOCK PLANS - Stock Incentive Plans (Details)       HTML     82K  
102: R80         STOCK PLANS - Compensation Expense (Details)        HTML     49K  
103: R81         STOCK PLANS - Stock Option Activity (Details)       HTML     92K  
104: R82         STOCK PLANS - Valuation Assumptions (Details)       HTML     55K  
105: R83         STOCK PLANS - RSU Activity (Details)                HTML     60K  
106: R84         NET INCOME PER SHARE - Calculation (Details)        HTML     86K  
107: R85         NET INCOME PER SHARE - Antidilutive Securities      HTML     45K  
                (Details)                                                        
108: R86         INCOME TAXES - Current and Deferred Income Taxes    HTML     67K  
                (Details)                                                        
109: R87         INCOME TAXES - Reconciliation of Effective Tax      HTML     92K  
                Rate (Details)                                                   
110: R88         INCOME TAXES - Narrative (Details)                  HTML     76K  
111: R89         INCOME TAXES - Deferred Tax Assets and Liabilities  HTML     60K  
                (Details)                                                        
112: R90         INCOME TAXES - Unrecognized Tax Benefits (Details)  HTML     37K  
113: R91         Employee Benefit Plans (Details)                    HTML     54K  
114: R92         Contingent Consideration (GAINS) CHARGES,           HTML     66K  
                ACQUISITION-RELATED CHARGES AND OTHER - Impairment               
                and Other (Details)                                              
115: R93         Contingent Consideration (GAINS) CHARGES,           HTML     62K  
                ACQUISITION-RELATED CHARGES AND OTHER - Narrative                
                (Details)                                                        
116: R94         Commercial Partners and Other Agreements (Details)  HTML     94K  
117: R95         Commitments and Contingencies (Details)             HTML     72K  
118: R96         Subsequent Event (Details)                          HTML     36K  
120: XML         IDEA XML File -- Filing Summary                      XML    205K  
123: XML         XBRL Instance -- pcrx-20231231_htm                   XML   3.07M  
119: EXCEL       IDEA Workbook of Financial Report Info              XLSX    255K  
19: EX-101.CAL  XBRL Calculations -- pcrx-20231231_cal               XML    301K 
20: EX-101.DEF  XBRL Definitions -- pcrx-20231231_def                XML   1.22M 
21: EX-101.LAB  XBRL Labels -- pcrx-20231231_lab                     XML   2.91M 
22: EX-101.PRE  XBRL Presentations -- pcrx-20231231_pre              XML   1.80M 
18: EX-101.SCH  XBRL Schema -- pcrx-20231231                         XSD    276K 
121: JSON        XBRL Instance as JSON Data -- MetaLinks              769±  1.14M  
122: ZIP         XBRL Zipped Folder -- 0001396814-24-000030-xbrl      Zip   1.33M  




        
Filing Submission 0001396814-24-000030 – SGML Text

Original SGML Text submitted by:  Pacira BioSciences, Inc.

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 1:09:14.3am ET